Maureen Sampson
Overview
Explore the profile of Maureen Sampson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
903
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zubiran R, Vargas-Vazquez A, Olvera F, Cruz-Bautista I, Martagon-Rosado A, Sampson M, et al.
Atherosclerosis
. 2023 Nov;
386:117364.
PMID: 37984194
Introduction: Low-density cholesterol (LDL-C) has long been estimated by the Friedewald formula (F-LDL-C); however, this method underestimates LDL-C in patients with hypertriglyceridemia (HTG) or low LDL-C levels. The Martin (M-LDL-C)...
12.
Fowler A, Van Rompay K, Sampson M, Leo J, Watanabe J, Usachenko J, et al.
NPJ Vaccines
. 2023 Sep;
8(1):142.
PMID: 37770440
Elevated low-density lipoprotein cholesterol (LDL-C) is an important risk factor in the development of atherosclerotic cardiovascular disease (ASCVD). Inhibitors of proprotein convertase subtilisin/kexin type 9 (PCSK9), a negative regulator of...
13.
Ortiz-Whittingham L, Baumer Y, Pang A, Sampson M, Baez A, Rose R, et al.
Psychoneuroendocrinology
. 2023 Aug;
157:106346.
PMID: 37651859
Introduction: Neighborhood socioeconomic deprivation is associated with increased cardiovascular risk factors, including inflammation. Inflammation plays an important role in modifying the cardioprotective function of high-density lipoprotein (HDL). Moreover, recent studies...
14.
Cole J, Sampson M, van Deventer H, Remaley A
Clin Chem
. 2023 Aug;
69(10):1145-1154.
PMID: 37624942
Background: The standard lipid panel forms the backbone of atherosclerotic cardiovascular disease risk assessment. Suboptimal analytical performance, along with biological variability, could lead to erroneous risk assessment and management decisions....
15.
Ahsan L, Zheng W, Kaur G, Kadakuntla A, Remaley A, Sampson M, et al.
Am J Cardiol
. 2023 Jul;
203:212-218.
PMID: 37499601
Lipoprotein subfractions (LS) can be used for better risk stratification in subjects deemed not at high risk for coronary artery disease (CAD). In this study, we evaluated the correlation between...
16.
Conners K, Shearer J, Joo J, Park H, Manemann S, Remaley A, et al.
JACC Heart Fail
. 2023 Jul;
12(2):290-300.
PMID: 37480881
Background: Inflammation and protein energy malnutrition are associated with heart failure (HF) mortality. The metabolic vulnerability index (MVX) is derived from markers of inflammation and malnutrition and measured by nuclear...
17.
Fowler A, Van Rompay K, Sampson M, Leo J, Watanabe J, Usachenko J, et al.
bioRxiv
. 2023 Jun;
PMID: 37292981
Elevated low-density lipoprotein cholesterol (LDL-C) is an important risk factor in the development of atherosclerotic cardiovascular disease (ASCVD). Inhibitors of proprotein convertase subtilisin/kexin type 9 (PCSK9), a negative regulator of...
18.
Sorokin A, Patel N, Li H, Hong C, Sampson M, OHagan R, et al.
Lipids Health Dis
. 2023 Apr;
22(1):55.
PMID: 37106374
Background: Psoriasis (PSO) is a skin disorder with systemic inflammation and high coronary artery disease risk. A distinct lipid phenotype occurs in psoriasis, which is characterized by high plasma triglycerides...
19.
Goksoyr L, Skrzypczak M, Sampson M, Nielsen M, Salanti A, Theander T, et al.
Vaccines (Basel)
. 2023 Jan;
11(1).
PMID: 36679847
Administration of PCSK9-specific monoclonal antibodies, as well as peptide-based PCSK9 vaccines, can lower plasma LDL cholesterol by blocking PCSK9. However, these treatments also cause an increase in plasma PCSK9 levels,...
20.
Sampson M, Wolska A, Cole J, Zubiran R, Otvos J, Meeusen J, et al.
Biomedicines
. 2022 Dec;
10(12).
PMID: 36551912
New more effective lipid-lowering therapies have made it important to accurately determine Low-density lipoprotein-cholesterol (LDL-C) at both high and low levels. LDL-C was measured by the β-quantification reference method (BQ)...